600812.SH
华北制药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 4.61
−6.11%Margins
Gross margin
31.0%
EBITDA margin
14.3%
EBIT margin
3.6%
Net margin
1.8%
FCF margin
7.1%
2.9%
Return on equity
0.8%
Return on assets
2.2%
Return on invested capital
0.41x
Asset turnover
CNY 1.2B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026